Unlike earlier waves of generic competition, many Chinese manufacturers already have experience producing and commercialising GLP-1s, raising expectations of fast market entry once the legal window opens
For patients with needle phobia or strong preferences for oral GLP-1 medication, compounded tirzepatide tablets offer an alternative worth considering with appropriate counseling about the differences in evidence
Untreated chronic obesity can progress into diabetes, heart disease, sleep apnea, kidney disease, disability and other expensive conditions
Angiogenesis and inflammation in the retinopathy risk of insulin and semaglutide - a review
Another effect of aging is capillary loss, accompanied by a decline in SIRT1 activity and NAD + levels
This can lead to issues like constipation, vomiting, and problems with nutrient and water absorption